These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6126197)

  • 1. Psychopharmacological profile of dapiprazole, a new potential antipsychotic agent.
    Silvestrini B; Lisciani R; Baldini A; de Sanctis AJ
    Arzneimittelforschung; 1982; 32(6):668-73. PubMed ID: 6126197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General pharmacological properties of dapiprazole, a potential psychotropic agent.
    Lisciani R; Baldini A; Silvestrini B
    Arzneimittelforschung; 1982; 32(6):674-8. PubMed ID: 6126198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dapiprazole on pupillary size and intraocular pressure in rabbits.
    Silvestrini B; Bonomi L; Lisciani R; Perfetti S; Belluci R; Massa F; Baldini A
    Arzneimittelforschung; 1982; 32(6):678-81. PubMed ID: 6126199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amoxapine in experimental psychopharmacology: a neuroleptic or an antidepressant?
    Chermat R; Simon P; Boissier JR
    Arzneimittelforschung; 1979; 29(5):814-20. PubMed ID: 40575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation of clomacran, a new potent psychotropic agent.
    Fowler PJ; Zirkle CL; Macko E; Kaiser C; Sarau H; Tedeschi DH
    Arzneimittelforschung; 1977; 27(4):866-72. PubMed ID: 17419
    [No Abstract]   [Full Text] [Related]  

  • 6. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacological profile of MD 790501, a new benzamide derivative.
    Jalfre M; Bucher B; Dorme N; Mocquet G; Porsolt RD
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):232-56. PubMed ID: 6139097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacological profile of mesterolone.
    Baran L; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological study of the thiophene analogue of taclamine, QM-7184, a new neuroleptic drug with potent alpha-adrenoceptor blocking activity.
    Arribas E; Vega S; Benito C; Fernandez-Tome MP; del Rio J
    Arzneimittelforschung; 1983; 33(10):1417-21. PubMed ID: 6140017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alcohol withdrawal syndrome. Effects of short-term treatment with dapiprazole].
    Bono G; Verri AP; Merlo P; Mancuso A; Sinforiani E; Mazzella GL
    Minerva Med; 1988 Dec; 79(12):1085-9. PubMed ID: 2905435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV; Arnt J; Hyttel J; Svendsen O
    Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals.
    Fowler PJ; Zirkle CL; Macko E; Setler PE; Sarau HM; Misher A; Tedeschi DH
    Arzneimittelforschung; 1977; 27(8):1589-95. PubMed ID: 410422
    [No Abstract]   [Full Text] [Related]  

  • 15. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives.
    Korzycka L; Szadowska A; Pakulska W
    Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 18. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
    Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
    J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
    Fukushiro DF; Carvalho Rde C; Ricardo VP; Alvarez Jdo N; Ribeiro LT; Frussa-Filho R
    Brain Res Bull; 2008 Sep; 77(2-3):124-8. PubMed ID: 18721669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1-(H)-pyrazino ]1,2-a] quinoline hydrochloride (compound 69/183). Part III: Assessment of tranquillising activity.
    Singh GB; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1978; 28(8):1403-6. PubMed ID: 37855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.